Medrexs Corporation completed the payment for the 35th warrants via third-party allotment on June 5, 2026, with potential shares outstanding reaching 14,782,000 shares and funding raised approximately 1,006,584,020 yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4586","jir_company_name":"Medrexs Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-06-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/4586-20260605-01.pdf","jir_short_summary":"Medrexs Corporation completed the payment for the 35th warrants via third-party allotment on June 5, 2026, with potential shares outstanding reaching 14,782,000 shares and funding raised approximately 1,006,584,020 yen.","jir_summary":"### Overview of Capital Policy\nMedrexs Corporation completed the issuance and payment for the 35th warrants via third-party allotment on June 5, 2026. The warrants issued numbered 147,820 units, with potential shares outstanding reaching 14,782,000 shares. The exercise price was initially 69 yen, and the exercise period is from June 8, 2026, to June 11, 2027. The funds raised amounted to approximately 1,006,584,020 yen, which are expected to be used for future capital strengthening and business investments.\n\n### Impact on Shareholders and Future Outlook\nThe issuance of these warrants increases potential shares outstanding, which may cause stock dilution risk. However, the funds obtained are expected to support business expansion and R&D promotion. The exercise price is linked to market stock prices and may be adjusted, potentially encouraging exercise depending on stock price movements. Going forward, monitoring exercise status and fund utilization will be essential.","jir_financial_highlights":"Potential Shares Outstanding: 14,782,000 shares (unknown)\nFunds Raised: approximately 1,006,584,020 yen (unknown)\nNumber of Warrants Issued: 147,820 units (unknown)","jir_category":"","jir_hashtags":"#Medrexs, #CapitalPolicy, #JapanStocks","jir_key_figures":"Potential Shares Outstanding: 14,782,000 shares\nFunds Raised: approximately 1,006,584,020 yen\nNumber of Warrants: 147,820 units","jir_meta_title":"\u3010Medrexs\u3011Warrant Issuance Completed\uff5cFunding of Approximately 100 Million Yen in June 2026","jir_meta_description":"Medrexs Corporation completed the payment for warrants on June 5, 2026, with potential shares outstanding reaching 14,782,000 shares and funds raised approximately 1,006,584,020 yen. Future business expansion is expected.","jir_og_title":"\u3010Medrexs\u3011Warrant Issuance Completed\uff5cFunding of Approximately 100 Million Yen in June 2026","jir_og_description":"Medrexs Corporation has completed warrant payment, with potential shares outstanding reaching 14,782,000 shares and funds raised approximately 1,006,584,020 yen. Future business growth is anticipated.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59495,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-61794","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n